vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and OIL STATES INTERNATIONAL, INC (OIS). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $178.5M, roughly 1.6× OIL STATES INTERNATIONAL, INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -65.7%, a 162.0% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 8.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 3.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Oil States International, Inc. is an American multinational corporation. It focuses on providing services to oil and gas companies. It is a public company listed on the New York Stock Exchange.
ACAD vs OIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $178.5M |
| Net Profit | $273.6M | $-117.2M |
| Gross Margin | 90.8% | 10.9% |
| Operating Margin | 6.1% | -63.7% |
| Net Margin | 96.3% | -65.7% |
| Revenue YoY | 9.4% | 8.4% |
| Net Profit YoY | 90.3% | -873.2% |
| EPS (diluted) | $1.61 | $-1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $178.5M | ||
| Q3 25 | $278.6M | $165.2M | ||
| Q2 25 | $264.6M | $165.4M | ||
| Q1 25 | $244.3M | $159.9M | ||
| Q4 24 | $259.6M | $164.6M | ||
| Q3 24 | $250.4M | $174.3M | ||
| Q2 24 | $242.0M | $186.4M | ||
| Q1 24 | $205.8M | $167.3M |
| Q4 25 | $273.6M | $-117.2M | ||
| Q3 25 | $71.8M | $1.9M | ||
| Q2 25 | $26.7M | $2.8M | ||
| Q1 25 | $19.0M | $3.2M | ||
| Q4 24 | $143.7M | $15.2M | ||
| Q3 24 | $32.8M | $-14.3M | ||
| Q2 24 | $33.4M | $1.3M | ||
| Q1 24 | $16.6M | $-13.4M |
| Q4 25 | 90.8% | 10.9% | ||
| Q3 25 | 92.2% | 22.1% | ||
| Q2 25 | 92.2% | 24.2% | ||
| Q1 25 | 91.7% | 23.3% | ||
| Q4 24 | 91.6% | 23.7% | ||
| Q3 24 | 92.5% | 21.7% | ||
| Q2 24 | 92.5% | 23.8% | ||
| Q1 24 | 88.8% | 21.1% |
| Q4 25 | 6.1% | -63.7% | ||
| Q3 25 | 12.8% | 2.9% | ||
| Q2 25 | 12.2% | 3.2% | ||
| Q1 25 | 7.9% | 3.5% | ||
| Q4 24 | 59.1% | 11.2% | ||
| Q3 24 | 12.6% | -6.3% | ||
| Q2 24 | 12.6% | 1.1% | ||
| Q1 24 | 7.4% | -6.7% |
| Q4 25 | 96.3% | -65.7% | ||
| Q3 25 | 25.8% | 1.2% | ||
| Q2 25 | 10.1% | 1.7% | ||
| Q1 25 | 7.8% | 2.0% | ||
| Q4 24 | 55.4% | 9.2% | ||
| Q3 24 | 13.1% | -8.2% | ||
| Q2 24 | 13.8% | 0.7% | ||
| Q1 24 | 8.0% | -8.0% |
| Q4 25 | $1.61 | $-1.99 | ||
| Q3 25 | $0.42 | $0.03 | ||
| Q2 25 | $0.16 | $0.05 | ||
| Q1 25 | $0.11 | $0.05 | ||
| Q4 24 | $0.86 | $0.24 | ||
| Q3 24 | $0.20 | $-0.23 | ||
| Q2 24 | $0.20 | $0.02 | ||
| Q1 24 | $0.10 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $69.9M |
| Total DebtLower is stronger | — | $1.7M |
| Stockholders' EquityBook value | $1.2B | $573.2M |
| Total Assets | $1.6B | $883.4M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $69.9M | ||
| Q3 25 | $258.0M | $67.1M | ||
| Q2 25 | $253.6M | $53.9M | ||
| Q1 25 | $217.7M | $66.8M | ||
| Q4 24 | $319.6M | $65.4M | ||
| Q3 24 | $155.1M | $46.0M | ||
| Q2 24 | $177.1M | $25.2M | ||
| Q1 24 | $204.7M | $24.1M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $124.7M | ||
| Q4 24 | — | $124.7M | ||
| Q3 24 | — | $124.6M | ||
| Q2 24 | — | $124.3M | ||
| Q1 24 | — | $135.6M |
| Q4 25 | $1.2B | $573.2M | ||
| Q3 25 | $917.3M | $689.0M | ||
| Q2 25 | $822.4M | $690.6M | ||
| Q1 25 | $765.2M | $683.4M | ||
| Q4 24 | $732.8M | $680.7M | ||
| Q3 24 | $577.2M | $684.8M | ||
| Q2 24 | $516.7M | $690.4M | ||
| Q1 24 | $464.0M | $692.3M |
| Q4 25 | $1.6B | $883.4M | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.2B | $993.7M | ||
| Q1 25 | $1.1B | $990.7M | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $976.9M | $994.1M | ||
| Q2 24 | $914.1M | $1.0B | ||
| Q1 24 | $855.1M | $1.0B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.18× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $50.1M |
| Free Cash FlowOCF − Capex | — | $47.1M |
| FCF MarginFCF / Revenue | — | 26.4% |
| Capex IntensityCapex / Revenue | — | 1.7% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $73.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $50.1M | ||
| Q3 25 | $74.3M | $30.7M | ||
| Q2 25 | $64.0M | $15.0M | ||
| Q1 25 | $20.3M | $9.3M | ||
| Q4 24 | $40.4M | $18.2M | ||
| Q3 24 | $63.2M | $28.8M | ||
| Q2 24 | $25.0M | $10.2M | ||
| Q1 24 | $29.1M | $-11.4M |
| Q4 25 | — | $47.1M | ||
| Q3 25 | $73.9M | $22.0M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $137.0K | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $63.2M | $21.4M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $-21.5M |
| Q4 25 | — | 26.4% | ||
| Q3 25 | 26.5% | 13.3% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 25.2% | 12.3% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | -12.8% |
| Q4 25 | — | 1.7% | ||
| Q3 25 | 0.1% | 5.3% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 5.7% | ||
| Q4 24 | — | 8.6% | ||
| Q3 24 | 0.0% | 4.3% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 6.0% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 16.15× | ||
| Q2 25 | 2.40× | 5.33× | ||
| Q1 25 | 1.07× | 2.94× | ||
| Q4 24 | 0.28× | 1.20× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 7.87× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
OIS
| Project Driven | $112.6M | 63% |
| Downhole Technologies | $32.1M | 18% |
| Completion And Production Services | $23.1M | 13% |
| Military And Other Products | $10.7M | 6% |
